Anastasia Suraev

Acute Effects of Oral Cannabinoids on Sleep and High‐Density <scp>EEG</scp> in Insomnia: A Pilot Randomised Controlled Trial

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)

Evaluating possible ‘next day’ impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial

Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (‘CUPID’ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial

Cannabinoids, Insomnia, and Other Sleep Disorders

Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies

Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research

Driving-Related Behaviours, Attitudes and Perceptions among Australian Medical Cannabis Users: Results from the CAMS 18-19 Survey

Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use